Bafna Pharmaceuticals is looking to raise funds from various routes and is also in early stages of negotiations. Separately, the US-based generic drug maker Mylan Inc and two Indian pharma companies are reportedly in the race to acquire this Chennai-based Company.
Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.